Home » Topics » BioWorld Science

BioWorld Science
RSS

PKMYT1 inhibitors discovered at Repare Therapeutics

Oct. 25, 2021

Monash University divulges antibiotic peptide-drug conjugates

Oct. 25, 2021

Bayer and collaborators describe new EGFR inhibitors

Oct. 25, 2021

CHD8 haploinsufficiency leads to seizure phenotype

Oct. 25, 2021

Biallelic variants in the KARS1 gene tied to neurodevelopmental disorders and hearing loss

Oct. 25, 2021

Understanding DNA repair mechanisms allows for crisper CRISPR genome editing

Oct. 25, 2021

Regeneron ADC REGN3124-PBD prolongs survival in mice with intracranial glioblastoma tumors

Oct. 22, 2021

Splice variant in DEGS1 leads to hypomyelinating leukodystrophy-like phenotype

Oct. 22, 2021

Atreca and Gates MRI enter licensing agreement on MAM-01 for malaria

Oct. 22, 2021

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Oct. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...